Cargando…
Genetic signature detected in T cell receptors from patients with severe COVID-19
Characterization of host genetic factors contributing to COVID-19 severity promises advances on drug discovery to fight the disease. Most genetic analyses to date have identified genome-wide significant associations involving loss-of-function variants for immune response pathways. Despite accumulati...
Autores principales: | Corpas, Manuel, de Mendoza, Carmen, Moreno-Torres, Víctor, Pintos, Ilduara, Seoane, Pedro, Perkins, James R., Ranea, Juan A.G., Fatumo, Segun, Korcsmaros, Tamas, Martín-Villa, José Manuel, Barreiro, Pablo, Corral, Octavio, Soriano, Vicente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504482/ https://www.ncbi.nlm.nih.gov/pubmed/37720084 http://dx.doi.org/10.1016/j.isci.2023.107735 |
Ejemplares similares
-
Generalisation of genomic findings and applications of polygenic risk scores
por: Corpas, Manuel, et al.
Publicado: (2023) -
How Not to Be a Bioinformatician
por: Corpas, Manuel, et al.
Publicado: (2012) -
Third wave of COVID-19 in Madrid, Spain
por: Soriano, Vicente, et al.
Publicado: (2021) -
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy
por: Soriano, Vicente, et al.
Publicado: (2023) -
Use of antibiotics in respiratory viral infections
por: Fernández-Montero, José Vicente, et al.
Publicado: (2022)